Doctors Revision

ENT (Ear, Nose, Throat Conditions)

Atrophic Rhinitis

A chronic nasal condition characterized by progressive atrophy (thinning) of the nasal mucosa, submucosa, turbinate bones, and associated glands, leading to a widened nasal cavity filled with foul-smelling crusts.

Also known as: Ozena

Open in the interactive guide
On this page

Referral and warning signs

When to refer

Refer to ENT Specialist (HC4/H/RR) if: Diagnosis uncertain. No improvement after 2 weeks of appropriate douching and antibiotics. Complications develop. Consideration for surgery.

Red flags

  • Suspicion of underlying malignancy or specific granulomatous disease.
  • Significant epistaxis.
  • Signs of orbital or intracranial extension (rare).

Signs and symptoms

  • Nasal obstruction sensation (despite wide airway).
  • Offensive nasal odour (Ozaena): Foul smell noticed by others, but usually NOT by the patient (due to anosmia).
  • Thick, dry crust formation in the nasal cavity (greenish, yellow, or black).
  • Epistaxis (nosebleeds) when crusts are removed.
  • Anosmia (loss of sense of smell).
  • Headache.
  • Examination: Widened nasal cavities, visible posterior pharyngeal wall, extensive crusting, atrophic pale mucosa, potential septal perforation.

Risk factors

  • Unknown cause (Primary Atrophic Rhinitis).
  • Secondary causes: Chronic infections (Klebsiella ozaenae sometimes implicated), Syphilis, Leprosy, Tuberculosis, Rhinoscleroma. Post-surgical changes (aggressive turbinectomy). Radiation therapy. Chronic granulomatous diseases. Nutritional deficiencies (possibly Iron, Vit A/D). Autoimmune factors.
  • Association with HIV/AIDS and poor socioeconomic status mentioned in UCG.

Diagnosis

Clinical assessment

Diagnosis based on characteristic clinical picture: wide nasal cavities, extensive crusting, foul odour (reported by others), and anosmia.

Investigations

  • Nasal Endoscopy (specialist).
  • CT Scan of Sinuses (shows bony atrophy, wide cavities).
  • Swab/Biopsy of crusts/mucosa: For Culture & Sensitivity (bacterial/fungal), Histology (rule out malignancy/granulomatous disease), AFB stain (TB), specific tests (syphilis, leprosy).
  • Consider VDRL/RPR (Syphilis), HIV test.

Diagnostic criteria

Clinical findings of nasal crusting, foul odour, anosmia, and wide nasal cavity on examination, supported by investigations ruling out other causes.

Differential diagnosis

  • Chronic Sinusitis (usually purulent discharge, not foul crusts/atrophy).
  • Nasal Tumour.
  • Chronic Granulomatous Disease (Wegener's, Sarcoidosis).
  • Fungal Sinusitis (allergic or invasive).
  • Rhinoscleroma (early stages mentioned in UCG).

Management

Non-pharmacological management

  • Nasal Douching/Irrigation (Mainstay): Regular, frequent (at least BID) nasal irrigation with large volumes of warm saline solution (e.g., Normal Saline 0.9%) or alkaline solution (e.g., Sodium Bicarbonate 5% - 1 tsp in 100ml warm water) to remove crusts and moisturize mucosa. (LOC: HC3)
  • Manual removal of crusts if necessary.
  • Humidification of inspired air.

Pharmacological treatment

  • Topical Lubrication/Moisturization: Application of lubricant ointment (e.g., Tetracycline eye ointment 1% per UCG, Vaseline) or paraffin oil inside the nose BID after douching to prevent crusting. (LOC: HC3)
  • Antibiotics (Target secondary infection, reduce odour/crusting):
  • - UCG recommends empirical Amoxicillin 500mg TID for 14 days. (LOC: HC3)
  • - Consider culture-directed therapy if specific organism identified.
  • - Rifampicin sometimes used (anti-Klebsiella effect).
  • - Prolonged courses may be needed.
  • Treat Underlying Cause: (e.g., Anti-TB meds, Syphilis treatment).
  • Glucose-in-glycerine drops (local preparation sometimes used).
  • Systemic medications (e.g., Potassium Iodide, vasodilators) - limited evidence, specialist use.

Monitoring

Monitor crusting, odour, patient comfort. Reinforce regular nasal douching. Follow up every 2 weeks initially.

Complications

  • Epistaxis.
  • Secondary infections (sinusitis, otitis media).
  • Septal perforation.
  • Pharyngitis sicca / Laryngitis sicca.
  • Social isolation due to odour.
  • Depression.

Prevention

  • Treat underlying infections (TB, Syphilis etc.).
  • Conservative nasal surgery (avoiding excessive turbinate removal).
  • Good nutrition.

Patient education

  • Explanation of the chronic nature of the condition.
  • Critical importance and technique of regular nasal douching/irrigation.
  • How to apply topical lubricants.
  • Need for long-term management.
  • Reassurance regarding anosmia (patient often unaware of odour).
  • Importance of treating secondary infections.

Uganda-specific notes

Condition seen, sometimes associated with specific infections or post-surgical changes. Nasal douching with saline/bicarbonate and topical lubrication are key practical measures. Access to specialist care/surgery limited.

Surgical Management

  • Procedures aim to narrow nasal cavity / reduce crusting (e.g., Young's operation, partial turbinectomy implants) - specialist procedures with variable success.

References

  • Uganda Clinical Guidelines (UCG) 2023

    Chapter 21, Section 21.2.5

Scroll to Top